Charlotte Berthaud

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Immunohistochemistry as a tool for identifying EGFR amplification in CNS tumors.

Immunohistochemistry as a tool for identifying EGFR amplification in CNS tumors.

Journal: Brain pathology (Zurich, Switzerland)

Published: October 01, 2025

Diagnostic utility of NKX2.2 and CD99 in the central nervous system to distinguish Ewing sarcoma from its mimickers.

Diagnostic utility of NKX2.2 and CD99 in the central nervous system to distinguish Ewing sarcoma from its mimickers.

Journal: Acta neuropathologica communications

Published: August 11, 2025

New developments in grading meningiomas: The experience of the Hospital Sainte-Anne

New developments in grading meningiomas: The experience of the Hospital Sainte-Anne

Journal: Annales de pathologie

Published: June 05, 2025

MN1 immunohistochemistry is a sensitive diagnostic biomarker for primitive CNS tumors with MN1 fusion.

MN1 immunohistochemistry is a sensitive diagnostic biomarker for primitive CNS tumors with MN1 fusion.

Journal: Acta neuropathologica

Published: September 26, 2024

Utility of combining OLIG2 and SOX10 IHC expression in CNS tumours: promising biomarkers for subtyping paediatric- and adult-type gliomas.

Utility of combining OLIG2 and SOX10 IHC expression in CNS tumours: promising biomarkers for subtyping paediatric- and adult-type gliomas.

Journal: Histopathology

Published: October 30, 2023

Contributions and limitations of FISH analysis for the diagnosis of central nervous system tumors according to the 2021 WHO classification: Feedback from Sainte-Anne Hospital's Department of Neuropathology

Contributions and limitations of FISH analysis for the diagnosis of central nervous system tumors according to the 2021 WHO classification: Feedback from Sainte-Anne Hospital's Department of Neuropathology

Journal: Annales de pathologie

Published: September 05, 2022

ETV4 immunohistostaining is a sensitive and specific diagnostic biomarker for CIC-rearranged sarcoma of the central nervous system.

ETV4 immunohistostaining is a sensitive and specific diagnostic biomarker for CIC-rearranged sarcoma of the central nervous system.

Journal: Histopathology

Published: July 21, 2022

The use of immunohistochemical slides for performing FISH as a useful method of conserving tissue samples

The use of immunohistochemical slides for performing FISH as a useful method of conserving tissue samples

Journal: Annales de pathologie

Published: February 08, 2022

L1CAM Is Not a Reliable Diagnostic Biomarker for Distinguishing Supratentorial Ependymomas, ZFTA Fusion-Positive From Other Central Nervous System Tumors.

L1CAM Is Not a Reliable Diagnostic Biomarker for Distinguishing Supratentorial Ependymomas, ZFTA Fusion-Positive From Other Central Nervous System Tumors.

Journal: Journal of neuropathology and experimental neurology

Published: January 21, 2022

BCOR immunohistochemistry, but not SATB2 immunohistochemistry, is a sensitive and specific diagnostic biomarker for central nervous system tumours with BCOR internal tandem duplication.

BCOR immunohistochemistry, but not SATB2 immunohistochemistry, is a sensitive and specific diagnostic biomarker for central nervous system tumours with BCOR internal tandem duplication.

Journal: Histopathology

Published: June 07, 2021

Analysis of interference criteria for the validation of a method file: HPS staining after fixation with zinc-formalin in comparison to fixation with the classical 4% buffered formalin solution

Analysis of interference criteria for the validation of a method file: HPS staining after fixation with zinc-formalin in comparison to fixation with the classical 4% buffered formalin solution

Journal: Annales de pathologie

Published: April 27, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026